title: Rocuronium duration of action under sevoflurane, desflurane or propofol anaesthesia.
abstract: OBJECTIVE
  We conducted a prospective randomized study to evaluate whether the duration of action of a single bolus dose of rocuronium is influenced by maintenance of anaesthesia with sevoflurane, desflurane or propofol infusion.
  
  
  METHODS
  Fifty-seven ASA I-II patients undergoing elective abdominal surgery were enrolled in this study. Anaesthesia was induced with thiopental 3-5 mg kg(-1) or propofol 2.5 mg kg(-1) and fentanyl 5 microg kg(-1) and tracheal intubation was facilitated with rocuronium 0.9 mg kg(-1). Thereafter patients were randomly allocated to three different groups to receive sevoflurane, desflurane or propofol for maintenance of anaesthesia. Recovery of neuromuscular function was monitored by single twitch stimulation of the ulnar nerve and by recording the adductor pollicis response using accelerometry. Intergroup recovery times to 5% of control value of single twitch were analysed using analysis of variance with Bonferroni correction.
  
  
  RESULTS
  The mean (95% confidence interval) recovery time to 5% of control value of single twitch during desflurane anaesthesia was 90.18 (86.11-94.25) min. Significantly shorter recovery times were observed during sevoflurane or propofol anaesthesia, 58.86 (54.73-62.99) min and 51.11 (45.47-56.74) min, respectively (P < 0.001). There were also significant differences in the recovery time between groups receiving desflurane vs. sevoflurane (P < 0.001) and desflurane vs. propofol (P < 0.001).
  
  
  CONCLUSIONS
  Desflurane anaesthesia significantly prolongs the duration of action of rocuronium at 0.9 mg kg(-1) single bolus dose, compared to sevoflurane or propofol anaesthesia maintenance regimens.
authors.affiliation: AHEPA University Hospital, Anaesthesiology Department, Thessaloniki, Greece. mpanagio@panafonet.gr
authors.forename: P G
authors.initials: PG
authors.lastname: Maidatsi
authors.forename: A Th
authors.initials: AT
authors.lastname: Zaralidou
authors.forename: N K
authors.initials: NK
authors.lastname: Gorgias
authors.forename: E N
authors.initials: EN
authors.lastname: Amaniti
authors.forename: K A
authors.initials: KA
authors.lastname: Karakoulas
authors.forename: M M
authors.initials: MM
authors.lastname: Giala
mesh_terms: D000005:Abdomen / Q000601:surgery; D000328:Adult; D000732:Androstanols / Q000008:administration & dosage*; D000769:Anesthesia, Inhalation; D000771:Anesthesia, Intravenous; D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D000077335:Desflurane; D005260:Female; D006801:Humans; D007530:Isoflurane / Q000031:analogs & derivatives*; D008297:Male; D008738:Methyl Ethers; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage*; D015742:Propofol; D000077123:Rocuronium; D000077149:Sevoflurane; D013997:Time Factors
chemical_list: D000732:Androstanols; D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D008738:Methyl Ethers; D003473:Neuromuscular Nondepolarizing Agents; D000077149:Sevoflurane; D000077335:Desflurane; D007530:Isoflurane; D000077123:Rocuronium; D015742:Propofol